ZEISS and RIKEN Innovation establish partnership in bioengineering and data management
Synergizing RIKEN’s excellence in basic research in bioengineering with ZEISS’s expertise in imaging and sensing
Oberkochen/Germany, Tokyo/Japan | ZEISS Group
ZEISS and RIKEN Innovation Co., Ltd. today entered into a strategic collaboration agreement to jointly explore opportunities in aiming to identify projects where the combination of RIKEN’s expertise in bioengineering and image data manipulation and ZEISS’ leadership in optical solutions can accelerate bioengineering innovations and bring about a paradigm change in health care.
“We are proud to complement RIKEN’s broad-spectrum and extensive basic research through our expertise in biomedical imaging, which we see as a fundamental ingredient for turning bioengineering into viable healthcare solutions. The success of leading-edge research requires not only groundbreaking ideas but also access and management of advanced scientific equipment. Highest level of instrument availability and advanced image data management are key to efficient R&D”, said Dr. Stefan Sacré, Head of ZEISS in Japan.
RIKEN’s extensive R&D infrastructure and imaging resources provide an excellent base for collaboration between RIKEN and ZEISS. Hiroshi Matsumoto, President of RIKEN, commented, “Today’s Agreement with ZEISS, a corporation which has earned a high level of trust world-wide as a manufacturer of high-precision microscopes and optical instruments, represents a new kind of partnership that does not merely focus on separate research topics. I look forward to an environment in which our partners at ZEISS and researchers at RIKEN engage in free and open discussions, and for RIKEN Innovation to support both organizations in their strategic planning. I expect that this will lead to collaborative research activity of the highest level and the pioneering of new fields.”
RIKEN Innovation President Yoshihiro Aburatani added, “RIKEN Innovation was founded on September 5, 2019 as fully-owned subsidiary of RIKEN. Our purpose is to serve as an external entity to support RIKEN in promoting and facilitating industry-academia collaboration and to actively perform the work necessary for collaborative projects with industrial partners, which will put RIKEN’s research achievements to work for society. I am very happy for this opportunity to work with ZEISS, a highly respected corporation in the fields of optics and optoelectronics. We will work diligently so that this large-scale collaborative effort is successful, which will also serve to benefit society.”
Signing of the strategic collaboration agreement: Dr. Stefan Sacré, Head of ZEISS in Japan, Prof. Dr. Hiroshi Matsumoto, President of RIKEN, and Dr. Yoshihiro Aburatani, President RIKEN Innovation (from left).
About RIKEN
RIKEN is Japan’s largest and most comprehensive research organization that covers a vast array of science and technology including physics, engineering, chemistry, mathematics and information science, computational science, bioscience and medicine. It conducts cutting-edge research in these areas, as well as R&D that contributes to Japan’s industrial development. It has 10 research locations in Japan including Wako, Kobe, Osaka, Tokyo, Harima and Yokohama. For more information go to https://www.riken.jp/
RIKEN Innovation was established on September 5, 2019 as a company wholly owned by RIKEN, according to the new Japanese Law of Active Creation of Scientific Technology and Innovation. It is in charge of work related to collaborations between RIKEN and its industrial partners, with the mission of returning to society the fruits of research and innovation. For more information go to https://www.innovation-riken.jp


